Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Accumulated Expenses (2016 - 2025)

CorMedix has reported Other Accumulated Expenses over the past 11 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $2.3 million for Q4 2025, up 1749.19% from a year ago — trailing twelve months through Dec 2025 was $2.3 million (up 1749.19% YoY), and the annual figure for FY2025 was $2.3 million, up 1749.19%.
  • Other Accumulated Expenses reached $2.3 million in Q4 2025 per CRMD's latest filing, up from $278684.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $2.3 million in Q4 2025 and bottomed at $54763.0 in Q3 2023.
  • Median Other Accumulated Expenses over the past 5 years was $112783.0 (2021), compared with a mean of $242973.4.
  • Peak annual rise in Other Accumulated Expenses hit 1749.19% in 2025, while the deepest fall reached 68.76% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $94736.0 in 2021, then crashed by 31.96% to $64456.0 in 2022, then surged by 127.01% to $146324.0 in 2023, then dropped by 15.26% to $124000.0 in 2024, then soared by 1749.19% to $2.3 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for CRMD at $2.3 million in Q4 2025, $278684.0 in Q3 2025, and $136298.0 in Q2 2025.